209986-17-4

Basic information

• Product Name: γ-Secretase Inhibitor XXI
• Synonyms: γ-Secretase Inhibitor XXI;N-[(1S)-2-[[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide;CoMpound E (secretase inhibitor);DuPont E;g-Secretase Inhibitor XXI;γ-Secretase Inhibitor BZ;(S)-2-(2-(3,5-difluorophenyl)acetamido)-N-((S,Z)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanamide;(S)-2-(2-(3,5-difluorophenyl)acetamido)-N-((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanamide
• CAS NO: 209986-17-4
• Molecular Formula: C27H24F2N4O3
• Molecular Weight: 490.5012664
• EINECS: -0
• Mol File: 209986-17-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 778.6±60.0 °C(Predicted)
• Appearance: /
• Density: 1.31
• Storage Temp.: = -70C
• Solubility: Soluble in DMSO
• PKA: 12.54±0.40(Predicted)
• Sensitive: Light Sensitive
• CAS DataBase Reference: γ-Secretase Inhibitor XXI(CAS DataBase Reference)
• NIST Chemistry Reference: γ-Secretase Inhibitor XXI(209986-17-4)
• EPA Substance Registry System: γ-Secretase Inhibitor XXI(209986-17-4)

Safety Data

• Hazardous Substances Data: 209986-17-4(Hazardous Substances Data)

Usage

Uses

A cell-permeable, potent, selective, peptidomimetic, non-transition-state analog inhibitor of -secretase and Notch processing

Relevant articles and documents

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.